Found: 87
Select item for more details and to access through your institution.
Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05827-x
- By:
- Publication type:
- Article
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 6, p. 251, doi. 10.1159/000538143
- By:
- Publication type:
- Article
Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors—The CONKO 020 Investigation.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1194, doi. 10.3390/cancers16061194
- By:
- Publication type:
- Article
Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11979-3
- By:
- Publication type:
- Article
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 5, p. 863, doi. 10.1002/ijc.34760
- By:
- Publication type:
- Article
VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 4, p. 1049, doi. 10.3390/jcm13041049
- By:
- Publication type:
- Article
Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 388, doi. 10.3390/cancers16020388
- By:
- Publication type:
- Article
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41011-4
- By:
- Publication type:
- Article
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 348, doi. 10.1159/000531268
- By:
- Publication type:
- Article
Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last Decade.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 11, p. 3656, doi. 10.3390/jcm12113656
- By:
- Publication type:
- Article
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 9038, doi. 10.3390/ijms24109038
- By:
- Publication type:
- Article
Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2367, doi. 10.3390/cancers15082367
- By:
- Publication type:
- Article
Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.946850
- By:
- Publication type:
- Article
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.
- Published in:
- European Radiology, 2023, v. 33, n. 2, p. 1174, doi. 10.1007/s00330-022-09053-2
- By:
- Publication type:
- Article
EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3).
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5596, doi. 10.3390/cancers14225596
- By:
- Publication type:
- Article
Radiofrequency Electromagnetic Fields Cause Non-Temperature-Induced Physical and Biological Effects in Cancer Cells.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5349, doi. 10.3390/cancers14215349
- By:
- Publication type:
- Article
Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 19, p. 3180, doi. 10.3390/cells11193180
- By:
- Publication type:
- Article
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 836, doi. 10.1038/s41416-022-01854-y
- By:
- Publication type:
- Article
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Encorafenib in Combination With Cetuximab After Systemic Therapy in Patients With BRAF<sup>V600E</sup> Mutant Metastatic Colorectal Cancer: German Health Technology Assessment-Driven Analyses From the BEACON CRC Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 16, p. 4905, doi. 10.3390/jcm11164905
- By:
- Publication type:
- Article
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3631, doi. 10.3390/cancers14153631
- By:
- Publication type:
- Article
Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 949, doi. 10.1002/jha2.502
- By:
- Publication type:
- Article
PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.941666
- By:
- Publication type:
- Article
Klinische und molekulare Diagnostik.
- Published in:
- Trillium-Diagnostik, 2022, v. 20, n. 3, p. 184, doi. 10.47184/td.2022.03.03
- By:
- Publication type:
- Article
Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.870411
- By:
- Publication type:
- Article
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1826, doi. 10.3390/cancers14071826
- By:
- Publication type:
- Article
Continuing Progress in the Interdisciplinary Management of Peritoneal Metastases.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.751453
- By:
- Publication type:
- Article
Prognostic and Predictive Molecular Markers in Cholangiocarcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1026, doi. 10.3390/cancers14041026
- By:
- Publication type:
- Article
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE‐3).
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 11, p. 1935, doi. 10.1002/ijc.33747
- By:
- Publication type:
- Article
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. e2110, doi. 10.1002/onco.13955
- By:
- Publication type:
- Article
Survey of Long-Term Experiences of Sperm Cryopreservation in Oncological and Non-Oncological Patients: Usage and Reproductive Outcomes of a Large Monocentric Cohort.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.772809
- By:
- Publication type:
- Article
Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.670396
- By:
- Publication type:
- Article
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00926-7
- By:
- Publication type:
- Article
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91330-z
- By:
- Publication type:
- Article
Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1558, doi. 10.3390/cancers13071558
- By:
- Publication type:
- Article
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3130, doi. 10.3390/cancers12113130
- By:
- Publication type:
- Article
Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2947, doi. 10.3390/cancers12102947
- By:
- Publication type:
- Article
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 8, p. 2077, doi. 10.1007/s00432-020-03290-y
- By:
- Publication type:
- Article
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 7, p. 2389, doi. 10.1245/s10434-020-08219-w
- By:
- Publication type:
- Article
Partition: a surjective mapping approach for dimensionality reduction.
- Published in:
- Bioinformatics, 2020, v. 36, n. 3, p. 676, doi. 10.1093/bioinformatics/btz661
- By:
- Publication type:
- Article
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta‐analysis using TRIBE, MAVERICC and FIRE3.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 8, p. 2082, doi. 10.1002/ijc.32261
- By:
- Publication type:
- Article
Darmkrebs - Aktuelle Standards und Perspektiven in der Therapieführung.
- Published in:
- Kompass Onkologie, 2019, v. 6, n. 2, p. 73, doi. 10.1159/000500435
- By:
- Publication type:
- Article
Mit Antikörpern gegen Darmkrebs.
- Published in:
- Trillium-Diagnostik, 2019, v. 17, n. 2, p. 114
- By:
- Publication type:
- Article
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article